High Mobility Group Protein B1 Market Research Report

High Mobility Group Protein B1 Market by Product Type (Dociparstat Sodium, RBM-005, EV-007156) by Application / End /User (Autoimmune Disorders, Cerebral Infarction, Chemotherapy Effects, Cancer) Industry Analysis, Volume, Share, Growth,Challenges,Key Players, Trends, Regions and Forecast 2023-2029

Number of pages: 151 | Report Code: PSMR- PSMR-000104 | Report Format : PDF

Report Summary

High Mobility Group Protein B1 (HMGB1) also known as High mobility group box 1 or SBP-1 is protein encoded by HMGB1 gene. HMGB1 is secreted by immune cells such as monocytes , macrophages, and dendritic cells through leaderless secretory pathway. Activated macrophages and monocytes secrete HMGB1. High Mobility Group Box protein 1 (HMGB1) is a non-alkaline (non-histonic) DNA-binding protein, it is normally localized in the nucleus as part of the chromatin. High Mobility Group Protein B1 is member of chromatin proteins which also includes , HMG1, HMG 2, HMG 14, and HMG 17.  


HMGB1 with its high positive charge binds to DNA leads to oxidation, hyperacetylation and posttranslational modifications. HMGB1 is responsible for Stabilization of the nucleosomal structure and regulation of gene transcription in chromatin. It is released by necrotic cells hence act as chaperone to shuttle nuclei acids into the endosomal compartment of APCs. Nucleic acid sensors like TLR9 trigger due to High Mobility Group Protein B1 (HMGB1) . HMGB1 also has the ability to bind LPS, at the level of lipid A, possibly because of its high positive electric charge. It can chaperone to the CD14-TLR4 MD2 complex, increasing the response of macrophages to the LPS. 


High Mobility Group Protein B1 (HMGB1) has its importance in:

  • Cellular processes such as inflammation, cell differentiation and tumor cell migration.
  • Clearance of apoptotic cells, such as in autoimmune diseases
  • Splicing results in multiple transcript variants that encode the same protein.
  • Antibodies that neutralize HMGB1 can be used to protects against damage and tissue injury during arthritis, lupus erythematosus, colitis, sepsis, endotoxemia, and ischemia.
  • thermodynamic stability with electrostatic interactions between the acidic tail and the HMG box.
  • The C-terminal acidic tail of HMGB1 helps in the maintenance of protein stability.

High Mobility Group Protein B1 Market : Key Player

  • Affibody AB
  • Cantex Pharmaceuticals Inc
  • Dicerna Pharmaceuticals Inc
  • Evec Inc
  • Ribomic Inc

High Mobility Group Protein B1 Market: End User / Application Type

  • Autoimmune Disorders
  • Cerebral Infarction
  • Chemotherapy Effects
  • Cancer Treatment

High Mobility Group Protein B1 Market : Product Type

  • Dociparstat Sodium
  • RBM-005
  • EV-007156

Global High Mobility Group Protein B1 Market: Regional Analysis

  • North America
    • U.S.A
    • Canada
  • Europe
    • France
    • Germany
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South East Asia
  • Latin America
    • Brazil
  • Middle East and Africa

High Mobility Group Protein B1 Market Report delivers comprehensive analysis of :

  • Market Forecast for 2018-26
  • Market growth drivers
  • Challenges and Opportunities
  • Emerging and Current market trends
  • Market player Capacity, Production, Revenue (Value)
  • Supply (Production), Consumption, Export, Import analysis
  • End user/application Analysis

Report Coverage

ParametersDetails

Base Year

2022

Historical Data

2017-2022

Forecast Data

2023-2029

Regional Scope

North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW


Frequently Asked Questions (FAQ)


High Mobility Group Protein B1 Market report considers 2021 as the base year.




High Mobility Group Protein B1 Market report considers data for period 2016 to 2021 as the historical data to predict market forecast between 2022 to 2029.




Yes, report is inclusive in-detailed analysis of key players in High Mobility Group Protein B1 Market




High Mobility Group Protein B1 Market Study is broadly divided into North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW. Also these regions are further analysed as per various countries




High Mobility Group Protein B1 Market Report includes Market Segmentation, Regional outlook, Application Analysis, Competitive analysis, Supply-Demand Analysis, Pricing insight.




Yes, the report includes COVID 19 impact on the market.




Top

  Download Free Sample


    ×

    Select Licence Type
    High Mobility Group Protein B1 Market Research Report

      Single User -          $2550


      Corporate User -   $3550


    Why Profshare Market Research?

      High Data Accuracy

    Precise research methodology, numerous analysis models & up to date data resources to achieve the most accurate market values.


     Free Customization

    We can tailor the report as per your requirements & budget, Most of our clients prefer custom reports.


      Budget-Friendly Solutions

    We have quality market data for all types of budgets & so now get the best out of your market research budget.


      Quality Support

    Be assured regarding satisfactory analyst support & understand the research report in-detailed.